CASI Pharmaceuticals Inc (CASI)
5.10
-0.15
(-2.86%)
USD |
NASDAQ |
Nov 22, 12:26
CASI Pharmaceuticals Debt to Equity Ratio: 1.381 for Sept. 30, 2024
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
| Date | Value |
|---|---|
| September 30, 2024 | 1.381 |
| June 30, 2024 | 2.047 |
| March 31, 2024 | 1.202 |
| December 31, 2023 | 0.7819 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 0.00 |
| September 30, 2022 | 0.0486 |
| June 30, 2022 | 0.015 |
| March 31, 2022 | 0.00 |
| December 31, 2021 | 0.00 |
| September 30, 2021 | 0.0125 |
| June 30, 2021 | 0.0212 |
| March 31, 2021 | 0.0199 |
| December 31, 2020 | 0.0158 |
| September 30, 2020 | 0.00 |
| June 30, 2020 | 0.00 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.0168 |
| March 31, 2019 | 0.0144 |
| December 31, 2018 | 0.0137 |
| September 30, 2018 | 0.0132 |
| Date | Value |
|---|---|
| June 30, 2018 | 0.0179 |
| March 31, 2018 | 0.0222 |
| December 31, 2017 | 0.0389 |
| September 30, 2017 | 0.0961 |
| June 30, 2017 | 0.0878 |
| March 31, 2017 | 0.0776 |
| December 31, 2016 | 0.0718 |
| September 30, 2016 | 0.0927 |
| June 30, 2016 | 0.1475 |
| March 31, 2016 | 0.3175 |
| December 31, 2015 | -0.2407 |
| September 30, 2015 | -0.3081 |
| June 30, 2015 | -0.4162 |
| March 31, 2015 | -0.7736 |
| December 31, 2014 | -3.292 |
| September 30, 2014 | 1.632 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 0.00 |
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 0.00 |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
--
Minimum
Dec 2019
2.047
Maximum
Jun 2024
0.2772
Average
0.0063
Median
Debt to Equity Ratio Benchmarks
| Sinovac Biotech Ltd | 0.0358 |
| Zai Lab Ltd | 0.1692 |
| China SXT Pharmaceuticals Inc | 0.1731 |
| Adagene Inc | -- |
| LakeShore Biopharma Co Ltd | -- |
Debt to Equity Ratio Related Metrics
| Total Assets (Quarterly) | 63.62M |
| Total Liabilities (Quarterly) | 49.77M |
| Shareholders Equity (Quarterly) | 13.85M |
| Current Ratio | 3.199 |
| Net Debt Paydown Yield | -4.02% |